In vivo induction of interleukin-1 during hemodialysis

In vivo induction of interleukin-1 during hemodialysis. In vivo induction of interleukin-1 (IL-1) production during hemodialysis was investigated by measuring IL-1 activity in monocyte lysates from 59 patients undergoing long-term maintenance hemodialysis with complement activating and non-complemen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Kidney international 1989-05, Vol.35 (5), p.1212-1218
Hauptverfasser: Haeffner-Cavaillon, Nicole, Cavaillon, Jean-Marc, Ciancioni, Christian, Bacle, Francoise, Delons, Simone, Kazatchkine, Michel D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1218
container_issue 5
container_start_page 1212
container_title Kidney international
container_volume 35
creator Haeffner-Cavaillon, Nicole
Cavaillon, Jean-Marc
Ciancioni, Christian
Bacle, Francoise
Delons, Simone
Kazatchkine, Michel D.
description In vivo induction of interleukin-1 during hemodialysis. In vivo induction of interleukin-1 (IL-1) production during hemodialysis was investigated by measuring IL-1 activity in monocyte lysates from 59 patients undergoing long-term maintenance hemodialysis with complement activating and non-complement activating devices. In patients dialyzed with new hollow-fiber cuprophane dialyzers, predialytic (TO) monocyte-associated IL-1 activity was 12.5 ± 3.0 U/ml (mean ± SEM), a value that was higher than that found in normal individuals (2.85 ± 0.85 U/ml; P < 0.0025) and in non-dialyzed patients with chronic renal failure (0.95 ± 0.85 U/ml, P < 0.0001). Cell-associated IL-1 activity was consistently increased after five hours of dialysis with cuprophane membranes (42.4 ± 5.5 U/ml, P < 0.0005). Systemic complement activation was demonstrated by the finding of increased plasma levels of C3adesArg antigen during dialysis. In patients dialyzed with high permeability polyacrylo-nitrile and polysulfone membranes, no intradialytic change in cell-associated IL-1 and no complement activation occurred. However, the mean predialytic values of monocyte-associated IL-1 in these patients (that is, 32.9 ± 5.6 U/ml and 38 ± 5.65 U/ml for the polyacrylonitrile and the polysulfone groups, respectively) were higher than the predialytic levels of cell-associated IL-1 in the patients from the cuprophane group (P < 0.0025). Monocytes obtained at the beginning and five hours of dialysis from patients dialyzed with polyacrylonitrile devices, and monocytes obtained at five hours but not at the beginning of dialysis from patients dialyzed with cuprophane membranes, spontaneously released extracellular IL-1 after 24 hours of culture in serum free conditions. Neither polyacrylonitrile nor cuprophane differed in their capacity to stimulate monocytes that had adhered to the membrane, to produce IL-1 in serum free cultures. These results indicate that IL-1 is transiently generated during hemodialysis with complement activating membranes when C3a/C3adesArg and C5a/C5adesArg, which are known inducers of IL-1 production, are generated in plasma Non-complement dependent factors, possibly LPS or fragments of LPS that often contaminate bicarbonate dialysates, may be responsible for chronic stimulation of IL-1 production in patients dialyzed with high permeability membranes.
doi_str_mv 10.1038/ki.1989.112
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79181334</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S008525381534549X</els_id><sourcerecordid>79181334</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3112-47c7f18fff35077abd4728062c3ca21b62f89b297e75b6f6a9c8dff1d54650523</originalsourceid><addsrcrecordid>eNptkEtLAzEURoMotVZXroVZiBuZmsdkkllK8VEouNF1yOShsTNJTTqF_nsjHbpydfm4h_s4AFwjOEeQ8Ie1m6OGN3OE8AmYIopJiRilp2AKIaclpoSfg4uUvmHODYETMMGMc1aTKaiXvti5XSic14PauuCLYHPYmtiZYe18iQo9ROc_iy_TB-1kt08uXYIzK7tkrsY6Ax_PT--L13L19rJcPK5KRfI1ZcUUs4hbawmFjMlWVwxzWGNFlMSorbHlTYsbZhhta1vLRnFtLdK0qinMj8zA3WHuJoafwaSt6F1SpuukN2FIgjWII0KqDN4fQBVDStFYsYmul3EvEBR_lsTaiT9LIt-V6Ztx7ND2Rh_ZUUvu3459mZTsbJReuXTEGMFNlbXOAD1gJivYORNFUs54ZbSLRm2FDu7f9b8snn_Z</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79181334</pqid></control><display><type>article</type><title>In vivo induction of interleukin-1 during hemodialysis</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Haeffner-Cavaillon, Nicole ; Cavaillon, Jean-Marc ; Ciancioni, Christian ; Bacle, Francoise ; Delons, Simone ; Kazatchkine, Michel D.</creator><creatorcontrib>Haeffner-Cavaillon, Nicole ; Cavaillon, Jean-Marc ; Ciancioni, Christian ; Bacle, Francoise ; Delons, Simone ; Kazatchkine, Michel D.</creatorcontrib><description>In vivo induction of interleukin-1 during hemodialysis. In vivo induction of interleukin-1 (IL-1) production during hemodialysis was investigated by measuring IL-1 activity in monocyte lysates from 59 patients undergoing long-term maintenance hemodialysis with complement activating and non-complement activating devices. In patients dialyzed with new hollow-fiber cuprophane dialyzers, predialytic (TO) monocyte-associated IL-1 activity was 12.5 ± 3.0 U/ml (mean ± SEM), a value that was higher than that found in normal individuals (2.85 ± 0.85 U/ml; P &lt; 0.0025) and in non-dialyzed patients with chronic renal failure (0.95 ± 0.85 U/ml, P &lt; 0.0001). Cell-associated IL-1 activity was consistently increased after five hours of dialysis with cuprophane membranes (42.4 ± 5.5 U/ml, P &lt; 0.0005). Systemic complement activation was demonstrated by the finding of increased plasma levels of C3adesArg antigen during dialysis. In patients dialyzed with high permeability polyacrylo-nitrile and polysulfone membranes, no intradialytic change in cell-associated IL-1 and no complement activation occurred. However, the mean predialytic values of monocyte-associated IL-1 in these patients (that is, 32.9 ± 5.6 U/ml and 38 ± 5.65 U/ml for the polyacrylonitrile and the polysulfone groups, respectively) were higher than the predialytic levels of cell-associated IL-1 in the patients from the cuprophane group (P &lt; 0.0025). Monocytes obtained at the beginning and five hours of dialysis from patients dialyzed with polyacrylonitrile devices, and monocytes obtained at five hours but not at the beginning of dialysis from patients dialyzed with cuprophane membranes, spontaneously released extracellular IL-1 after 24 hours of culture in serum free conditions. Neither polyacrylonitrile nor cuprophane differed in their capacity to stimulate monocytes that had adhered to the membrane, to produce IL-1 in serum free cultures. These results indicate that IL-1 is transiently generated during hemodialysis with complement activating membranes when C3a/C3adesArg and C5a/C5adesArg, which are known inducers of IL-1 production, are generated in plasma Non-complement dependent factors, possibly LPS or fragments of LPS that often contaminate bicarbonate dialysates, may be responsible for chronic stimulation of IL-1 production in patients dialyzed with high permeability membranes.</description><identifier>ISSN: 0085-2538</identifier><identifier>EISSN: 1523-1755</identifier><identifier>DOI: 10.1038/ki.1989.112</identifier><identifier>PMID: 2788763</identifier><identifier>CODEN: KDYIA5</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Cells, Cultured ; Complement System Proteins - analysis ; Emergency and intensive care: renal failure. Dialysis management ; Female ; Humans ; Intensive care medicine ; Interleukin-1 - biosynthesis ; Interleukin-1 - blood ; Kidney Failure, Chronic - immunology ; Kidney Failure, Chronic - therapy ; Kinetics ; Lipopolysaccharides - pharmacology ; Male ; Medical sciences ; Monocytes - drug effects ; Monocytes - immunology ; Renal Dialysis</subject><ispartof>Kidney international, 1989-05, Vol.35 (5), p.1212-1218</ispartof><rights>1989 International Society of Nephrology</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3112-47c7f18fff35077abd4728062c3ca21b62f89b297e75b6f6a9c8dff1d54650523</citedby><cites>FETCH-LOGICAL-c3112-47c7f18fff35077abd4728062c3ca21b62f89b297e75b6f6a9c8dff1d54650523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7329425$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2788763$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Haeffner-Cavaillon, Nicole</creatorcontrib><creatorcontrib>Cavaillon, Jean-Marc</creatorcontrib><creatorcontrib>Ciancioni, Christian</creatorcontrib><creatorcontrib>Bacle, Francoise</creatorcontrib><creatorcontrib>Delons, Simone</creatorcontrib><creatorcontrib>Kazatchkine, Michel D.</creatorcontrib><title>In vivo induction of interleukin-1 during hemodialysis</title><title>Kidney international</title><addtitle>Kidney Int</addtitle><description>In vivo induction of interleukin-1 during hemodialysis. In vivo induction of interleukin-1 (IL-1) production during hemodialysis was investigated by measuring IL-1 activity in monocyte lysates from 59 patients undergoing long-term maintenance hemodialysis with complement activating and non-complement activating devices. In patients dialyzed with new hollow-fiber cuprophane dialyzers, predialytic (TO) monocyte-associated IL-1 activity was 12.5 ± 3.0 U/ml (mean ± SEM), a value that was higher than that found in normal individuals (2.85 ± 0.85 U/ml; P &lt; 0.0025) and in non-dialyzed patients with chronic renal failure (0.95 ± 0.85 U/ml, P &lt; 0.0001). Cell-associated IL-1 activity was consistently increased after five hours of dialysis with cuprophane membranes (42.4 ± 5.5 U/ml, P &lt; 0.0005). Systemic complement activation was demonstrated by the finding of increased plasma levels of C3adesArg antigen during dialysis. In patients dialyzed with high permeability polyacrylo-nitrile and polysulfone membranes, no intradialytic change in cell-associated IL-1 and no complement activation occurred. However, the mean predialytic values of monocyte-associated IL-1 in these patients (that is, 32.9 ± 5.6 U/ml and 38 ± 5.65 U/ml for the polyacrylonitrile and the polysulfone groups, respectively) were higher than the predialytic levels of cell-associated IL-1 in the patients from the cuprophane group (P &lt; 0.0025). Monocytes obtained at the beginning and five hours of dialysis from patients dialyzed with polyacrylonitrile devices, and monocytes obtained at five hours but not at the beginning of dialysis from patients dialyzed with cuprophane membranes, spontaneously released extracellular IL-1 after 24 hours of culture in serum free conditions. Neither polyacrylonitrile nor cuprophane differed in their capacity to stimulate monocytes that had adhered to the membrane, to produce IL-1 in serum free cultures. These results indicate that IL-1 is transiently generated during hemodialysis with complement activating membranes when C3a/C3adesArg and C5a/C5adesArg, which are known inducers of IL-1 production, are generated in plasma Non-complement dependent factors, possibly LPS or fragments of LPS that often contaminate bicarbonate dialysates, may be responsible for chronic stimulation of IL-1 production in patients dialyzed with high permeability membranes.</description><subject>Adult</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Cells, Cultured</subject><subject>Complement System Proteins - analysis</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Interleukin-1 - biosynthesis</subject><subject>Interleukin-1 - blood</subject><subject>Kidney Failure, Chronic - immunology</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Kinetics</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Monocytes - drug effects</subject><subject>Monocytes - immunology</subject><subject>Renal Dialysis</subject><issn>0085-2538</issn><issn>1523-1755</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkEtLAzEURoMotVZXroVZiBuZmsdkkllK8VEouNF1yOShsTNJTTqF_nsjHbpydfm4h_s4AFwjOEeQ8Ie1m6OGN3OE8AmYIopJiRilp2AKIaclpoSfg4uUvmHODYETMMGMc1aTKaiXvti5XSic14PauuCLYHPYmtiZYe18iQo9ROc_iy_TB-1kt08uXYIzK7tkrsY6Ax_PT--L13L19rJcPK5KRfI1ZcUUs4hbawmFjMlWVwxzWGNFlMSorbHlTYsbZhhta1vLRnFtLdK0qinMj8zA3WHuJoafwaSt6F1SpuukN2FIgjWII0KqDN4fQBVDStFYsYmul3EvEBR_lsTaiT9LIt-V6Ztx7ND2Rh_ZUUvu3459mZTsbJReuXTEGMFNlbXOAD1gJivYORNFUs54ZbSLRm2FDu7f9b8snn_Z</recordid><startdate>198905</startdate><enddate>198905</enddate><creator>Haeffner-Cavaillon, Nicole</creator><creator>Cavaillon, Jean-Marc</creator><creator>Ciancioni, Christian</creator><creator>Bacle, Francoise</creator><creator>Delons, Simone</creator><creator>Kazatchkine, Michel D.</creator><general>Elsevier Inc</general><general>Nature Publishing</general><scope>6I.</scope><scope>AAFTH</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198905</creationdate><title>In vivo induction of interleukin-1 during hemodialysis</title><author>Haeffner-Cavaillon, Nicole ; Cavaillon, Jean-Marc ; Ciancioni, Christian ; Bacle, Francoise ; Delons, Simone ; Kazatchkine, Michel D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3112-47c7f18fff35077abd4728062c3ca21b62f89b297e75b6f6a9c8dff1d54650523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Adult</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Cells, Cultured</topic><topic>Complement System Proteins - analysis</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Interleukin-1 - biosynthesis</topic><topic>Interleukin-1 - blood</topic><topic>Kidney Failure, Chronic - immunology</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Kinetics</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Monocytes - drug effects</topic><topic>Monocytes - immunology</topic><topic>Renal Dialysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Haeffner-Cavaillon, Nicole</creatorcontrib><creatorcontrib>Cavaillon, Jean-Marc</creatorcontrib><creatorcontrib>Ciancioni, Christian</creatorcontrib><creatorcontrib>Bacle, Francoise</creatorcontrib><creatorcontrib>Delons, Simone</creatorcontrib><creatorcontrib>Kazatchkine, Michel D.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Kidney international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Haeffner-Cavaillon, Nicole</au><au>Cavaillon, Jean-Marc</au><au>Ciancioni, Christian</au><au>Bacle, Francoise</au><au>Delons, Simone</au><au>Kazatchkine, Michel D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In vivo induction of interleukin-1 during hemodialysis</atitle><jtitle>Kidney international</jtitle><addtitle>Kidney Int</addtitle><date>1989-05</date><risdate>1989</risdate><volume>35</volume><issue>5</issue><spage>1212</spage><epage>1218</epage><pages>1212-1218</pages><issn>0085-2538</issn><eissn>1523-1755</eissn><coden>KDYIA5</coden><abstract>In vivo induction of interleukin-1 during hemodialysis. In vivo induction of interleukin-1 (IL-1) production during hemodialysis was investigated by measuring IL-1 activity in monocyte lysates from 59 patients undergoing long-term maintenance hemodialysis with complement activating and non-complement activating devices. In patients dialyzed with new hollow-fiber cuprophane dialyzers, predialytic (TO) monocyte-associated IL-1 activity was 12.5 ± 3.0 U/ml (mean ± SEM), a value that was higher than that found in normal individuals (2.85 ± 0.85 U/ml; P &lt; 0.0025) and in non-dialyzed patients with chronic renal failure (0.95 ± 0.85 U/ml, P &lt; 0.0001). Cell-associated IL-1 activity was consistently increased after five hours of dialysis with cuprophane membranes (42.4 ± 5.5 U/ml, P &lt; 0.0005). Systemic complement activation was demonstrated by the finding of increased plasma levels of C3adesArg antigen during dialysis. In patients dialyzed with high permeability polyacrylo-nitrile and polysulfone membranes, no intradialytic change in cell-associated IL-1 and no complement activation occurred. However, the mean predialytic values of monocyte-associated IL-1 in these patients (that is, 32.9 ± 5.6 U/ml and 38 ± 5.65 U/ml for the polyacrylonitrile and the polysulfone groups, respectively) were higher than the predialytic levels of cell-associated IL-1 in the patients from the cuprophane group (P &lt; 0.0025). Monocytes obtained at the beginning and five hours of dialysis from patients dialyzed with polyacrylonitrile devices, and monocytes obtained at five hours but not at the beginning of dialysis from patients dialyzed with cuprophane membranes, spontaneously released extracellular IL-1 after 24 hours of culture in serum free conditions. Neither polyacrylonitrile nor cuprophane differed in their capacity to stimulate monocytes that had adhered to the membrane, to produce IL-1 in serum free cultures. These results indicate that IL-1 is transiently generated during hemodialysis with complement activating membranes when C3a/C3adesArg and C5a/C5adesArg, which are known inducers of IL-1 production, are generated in plasma Non-complement dependent factors, possibly LPS or fragments of LPS that often contaminate bicarbonate dialysates, may be responsible for chronic stimulation of IL-1 production in patients dialyzed with high permeability membranes.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>2788763</pmid><doi>10.1038/ki.1989.112</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0085-2538
ispartof Kidney international, 1989-05, Vol.35 (5), p.1212-1218
issn 0085-2538
1523-1755
language eng
recordid cdi_proquest_miscellaneous_79181334
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adult
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Cells, Cultured
Complement System Proteins - analysis
Emergency and intensive care: renal failure. Dialysis management
Female
Humans
Intensive care medicine
Interleukin-1 - biosynthesis
Interleukin-1 - blood
Kidney Failure, Chronic - immunology
Kidney Failure, Chronic - therapy
Kinetics
Lipopolysaccharides - pharmacology
Male
Medical sciences
Monocytes - drug effects
Monocytes - immunology
Renal Dialysis
title In vivo induction of interleukin-1 during hemodialysis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T19%3A36%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20vivo%20induction%20of%20interleukin-1%20during%20hemodialysis&rft.jtitle=Kidney%20international&rft.au=Haeffner-Cavaillon,%20Nicole&rft.date=1989-05&rft.volume=35&rft.issue=5&rft.spage=1212&rft.epage=1218&rft.pages=1212-1218&rft.issn=0085-2538&rft.eissn=1523-1755&rft.coden=KDYIA5&rft_id=info:doi/10.1038/ki.1989.112&rft_dat=%3Cproquest_cross%3E79181334%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=79181334&rft_id=info:pmid/2788763&rft_els_id=S008525381534549X&rfr_iscdi=true